Israel takes another step towards development of Coronavirus cure

May 17, 2020 by TPS
Read on for article

The Israel Institute for Biological Research (IIBR) in Ness Ziona has completed the patent registration for eight Coronavirus (COVID-19) antibodies, another significant step towards the production of a cure for the pandemic.

Infographic of the Coronavirus. Feb 22, 2020. Photo by Kobi Richter/TPS

IIBR Director-General Professor Shmuel Shapira informed Defense Minister Naftali Bennett that the Institute had completed the patent for eight antibodies to the violent virus as part of the drug development process.

Bennett said Friday that this was “another important step in developing a cure. The Biological Institute is working around the clock to find a solution that will save human lives.”

Earlier this month, the IIBR announced that it had made a significant breakthrough in the fight on the COVID-19 pandemic and had developed a potent antibody that attacks the virus.

The researchers have developed an antibody that attacks the virus uniquely and can neutralize it in a patient’s body.

After the patent registration process, the researchers will now contact international companies who can produce the antibody in commercial quantities.

To date, some 4,723,000 Coronavirus cases have been registered worldwide in 213 countries, with over 313,000 deaths and some 1,813,000 recoveries.

TPS

Speak Your Mind

Comments received without a full name will not be considered
Email addresses are NEVER published! All comments are moderated. J-Wire will publish considered comments by people who provide a real name and email address. Comments that are abusive, rude, defamatory or which contain offensive language will not be published


    Rules on posting comments